Mergers & Acquisitions Mergers & Acquisitions

Comment: AbbVie-Allergan deal awaits decision in final US FTC phase that takes weeks

By Jenna Ebersole
  • 06 Apr 2020 16:10
  • 06 Apr 2020 16:10
AbbVie and Allergan’s March announcement that they signed a consent decree agreement with US Federal Trade Commission staff was a major step forward for their merger, but the process to a final vote can still take a month or even longer.

The companies said March 17 that they had reached the agreement with

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News